Embla Medical hfOSSFF 92 PEG Ratio is 1.40 as of Jun. 25, 2026, which is 61% below its 10-year median of 3.55. GuruFocus rates OSSFF with a GF Score™ of 92/100 and a GF Value™ of $5.49. The stock has 2 warning signs investors should review. Among 206 Medical Devices & Instruments companies, Embla Medical hf ranks better than 62.14% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Embla Medical hf's PEG Ratio or its related term are showing as below:
OSSFF'
s PEG Ratio Range Over the Past 10 Years
Min: 1.36 Med: 3.55 Max: 58.41
Current: 1.36
During the past 13 years, Embla Medical hf's highest PEG Ratio was 58.41. The lowest was 1.36. And the median was 3.55.
OSSFF's PEG Ratio is ranked better than 62.14% of 206
companies
in the Medical Devices & Instruments industry
Industry Median: 1.95
vs OSSFF: 1.36
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Embla Medical hf (OTCPK:OSSFF) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Embla Medical hf PEG Ratio Related Terms
Embla Medical hf PEG Ratio Historical Data
* Premium members only.
The historical data trend for Embla Medical hf's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Embla Medical hf's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Embla Medical hf PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Embla Medical hf's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Embla Medical hf (OSSFF) has a PEG Ratio of 1.40 as of Jun. 25, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Embla Medical hf and its competitors. This is 61% below median its historical median of 3.55. Over the past decade, Embla Medical hf's PEG Ratio has ranged from 1.36 to 58.41. According to the industry distribution chart, Embla Medical hf ranks #78 out of 206 companies in the Medical Devices & Instruments industry, placing it in the top 37.9%.
Is Embla Medical hf's PEG Ratio too high?
Embla Medical hf's current PEG Ratio of 1.40 is 61% below median its 10-year median of 3.55. Over the past 10 years, this metric has ranged from a low of 1.36 to a high of 58.41. The Medical Devices & Instruments industry median PEG Ratio is 1.95. Embla Medical hf's value of 1.40 is 28.2% below this industry median. Based on the distribution chart, Embla Medical hf ranks #78 out of 206 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Embla Medical hf has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Embla Medical hf's PEG Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Embla Medical hf ranks #78 out of 206 companies for PEG Ratio. This puts Embla Medical hf in the upper half of its industry. The industry median PEG Ratio is 1.95. Embla Medical hf's value of 1.40 is 28.2% below this benchmark. Historically, Embla Medical hf's own PEG Ratio has ranged from 1.36 to 58.41 over the past decade. While the company's 10-year median is 3.55 vs. the industry median of 1.95, Embla Medical hf has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 1.95, based on 206 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Embla Medical hf's current PEG Ratio of 1.40 is 28.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Embla Medical hf and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 1.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Embla Medical hf's current PEG Ratio is 1.40, which is 61% below median its own 10-year median of 3.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embla Medical hf stock overvalued right now?
Embla Medical hf (OSSFF) has a current PEG Ratio of 1.40. The stock's GF Value™ is $5.49, compared to a current price of $4.15 — trading 24.4% below its estimated fair value. The current PEG Ratio is 1.40, which is 61% below median its 10-year median of 3.55 and 28.2% below the Medical Devices & Instruments industry median of 1.95. Embla Medical hf's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Embla Medical hf (OSSFF), the current PEG Ratio is 1.40 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Embla Medical hf (OSSFF) Overvalued in 2026?
Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued.
The current stock price of $4.15 is trading 24.4% below its estimated GF Value™ of $5.49.
Key valuation signals for OSSFF:
PEG Ratio: 1.40 (61% below median its 10-year median of 3.55)
GF Value™: $5.49 vs. price of $4.15 (24.4% below fair value)
Industry Position: 28.2% below the Medical Devices & Instruments median (#78 of 206)
No single metric tells the full story. See the OSSFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
92GF Score
Get the complete analysis for OSSFF
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSSFF has been successfully added to your 
